Investor profile
AdBio partners has backed 5 European tech companies across 6 funding rounds between 2022 and 2025, joining rounds totalling €145M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Arthex Biotech | Spain | 2 | €74M |
| DiogenX | France | 1 | €28M |
| Astraveus | France | 1 | €17M |
| Tridek-One | France | 1 | €16M |
| Integra Therapeutics | Spain |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Arthex Biotech | Series B | €42M | 2023-05 |
| Arthex Biotech | Series B | €32M | 2025-09 |
| DiogenX | Series A | €28M | 2023-05 |
| Astraveus |
| 1 |
| €11M |
| Seed |
| €17M |
| 2023-06 |
| Tridek-One | Other | €16M | 2022-09 |
| Integra Therapeutics | Seed | €11M | 2025-09 |
